» Articles » PMID: 26412981

Metabolic Dysfunction in Obstructive Sleep Apnea: A Critical Examination of Underlying Mechanisms

Overview
Date 2015 Sep 29
PMID 26412981
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

It has recently become clear that obstructive sleep apnea (OSA) is an independent risk factor for the development of metabolic syndrome, a disorder of defective energy storage and use. Several mechanisms have been proposed to explain this finding, drawing upon the characteristics that define OSA. In particular, intermittent hypoxia, sleep fragmentation, elevated sympathetic tone, and oxidative stress - all consequences of OSA - have been implicated in the progression of poor metabolic outcomes in OSA. In this review we examine the evidence to support each of these disease manifestations of OSA as a unique risk for metabolic dysfunction. Tissue hypoxia and sleep fragmentation are each directly connected to insulin resistance and hypertension, and each of these also may increase sympathetic tone, resulting in defective glucose homeostasis, excessive lipolysis, and elevated blood pressure. Oxidative stress further worsens insulin resistance and in turn, metabolic dysfunction also increases oxidative stress. However, despite many studies linking each of these individual components of OSA to the development of metabolic syndrome, there are very few reports that actually provide a coherent narrative about the mechanism underlying metabolic dysfunction in OSA.

Citing Articles

Link Between Obstructive Sleep Apnea and Kidney Stones: NHANES 2015-2018 and Mendelian Randomization.

Liu Y, Wang L, Bao E, Wang J, Yang L, Wang L Nat Sci Sleep. 2024; 16:1557-1568.

PMID: 39376546 PMC: 11457767. DOI: 10.2147/NSS.S483343.


Oxalate (dys)Metabolism: Person-to-Person Variability, Kidney and Cardiometabolic Toxicity.

Baltazar P, de Melo Junior A, Fonseca N, Lanca M, Faria A, Sequeira C Genes (Basel). 2023; 14(9).

PMID: 37761859 PMC: 10530622. DOI: 10.3390/genes14091719.


CaMKII-Dependent Contractile Dysfunction and Pro-Arrhythmic Activity in a Mouse Model of Obstructive Sleep Apnea.

Hegner P, Lebek S, Schaner B, Ofner F, Gugg M, Maier L Antioxidants (Basel). 2023; 12(2).

PMID: 36829874 PMC: 9952298. DOI: 10.3390/antiox12020315.


Association between Rapid Eye Movement Obstructive Sleep Apnea and Metabolic Syndrome in a Japanese Population.

Mano M, Nomura A, Hori R, Sasanabe R Intern Med. 2022; 62(13):1907-1913.

PMID: 36384898 PMC: 10372281. DOI: 10.2169/internalmedicine.0336-22.


Time Domains of Hypoxia Responses and -Omics Insights.

Yu J, Non A, Heinrich E, Gu W, Alcock J, Moya E Front Physiol. 2022; 13:885295.

PMID: 36035495 PMC: 9400701. DOI: 10.3389/fphys.2022.885295.


References
1.
da Rosa D, Forgiarini L, Baronio D, Feijo C, Martinez D, Marroni N . Simulating sleep apnea by exposure to intermittent hypoxia induces inflammation in the lung and liver. Mediators Inflamm. 2012; 2012:879419. PMC: 3513737. DOI: 10.1155/2012/879419. View

2.
Prabhakar N, Dick T, Nanduri J, Kumar G . Systemic, cellular and molecular analysis of chemoreflex-mediated sympathoexcitation by chronic intermittent hypoxia. Exp Physiol. 2006; 92(1):39-44. DOI: 10.1113/expphysiol.2006.036434. View

3.
Lentini S, Manka R, Scholtyssek S, Stoffel-Wagner B, Luderitz B, Tasci S . Creatine phosphokinase elevation in obstructive sleep apnea syndrome: an unknown association?. Chest. 2006; 129(1):88-94. DOI: 10.1378/chest.129.1.88. View

4.
Wang H, Wang Y, Zhang Y, Chen Y, Wang X, Liu Z . Changes in plasma angiotensin II and circadian rhythm of blood pressure in hypertensive patients with sleep apnea syndrome before and after treatment. Chin Med Sci J. 2011; 26(1):9-13. DOI: 10.1016/s1001-9294(11)60013-8. View

5.
Ryan S, Taylor C, McNicholas W . Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation. 2005; 112(17):2660-7. DOI: 10.1161/CIRCULATIONAHA.105.556746. View